Simon Lester
New Trump Tariffs Lead To New Lawsuit
After the Supreme Court struck down President Trump's IEEPA tariffs, his administration immediately turned to Section 122 of the Trade Act of 1974 for replacement tariffs (to be supplemented by additional tariffs under Section 301 of that same statute, as well as Section 232 of the Trade Expansion
New EU Legislative Initiative Promotes EU Industry, Targets China
The EU is moving forward with an industrial policy plan that uses discriminatory procurement policies to promote manufacturing in the EU, with Chinese producers and policies as the main target.
USTR Issues 2025 Report on Notorious Markets for Counterfeiting and Piracy
Today, the Office of the U.S. Trade Representative issued its 2025 Review of Notorious Markets for Counterfeiting and Piracy (Notorious Markets List, or NML), which "highlights prominent and illustrative examples of online and physical markets that reportedly engage in, facilitate, turn a blind eye to, or benefit from
Solar Companies Set Out Arguments in "Transnational Subsidies" Appeal at CIT
In recent filings with the U.S. Court of International Trade (CIT), several solar companies have presented their arguments that the Commerce Department erred by treating "transnational subsidies" from China as countervailable.
Canada Publishes Guidance for TRQ on Chinese EV Imports
Last week, the Canadian government informed importers "of the rules and procedures governing the administration of the quota for imports of electric vehicles (EVs) from the People’s Republic of China (China)."
CTM Weekly Newsletter
This past week, CTM covered the following issues.
In a major development related to the Trump administration's tariff strategy, last Friday the Supreme Court held that the International Emergency Economic Powers Act (IEEPA), under which the Trump administration had justified many of its tariffs on China and other
USITC To Investigate Revoking PNTR, Chinese Biotech Support
The U.S. International Trade Commission (USITC) has announced two new investigations related to China, one on revoking Permanent Normal Trade Relations (PNTR) and the other on government support for the biotech sector.